ClinicalTrials.Veeva

Menu

OSA Screen Negative With Spinal Duramorph

Wake Forest University (WFU) logo

Wake Forest University (WFU)

Status

Terminated

Conditions

Respiratory Depression

Treatments

Device: Capnography monitoring

Study type

Interventional

Funder types

Other

Identifiers

NCT03151226
IRB00033095

Details and patient eligibility

About

Non emergent scheduled cesarean sections will be consented to participate in this study of patients who have screened negative for obstructive sleep apnea and who are also BMI>/= 35 to have capnography monitoring postoperatively. The capnography and pulse oximetry will be initiated in the post anesthesia care unit and be worn for 12-24 hours after delivery. Data will be retrieved after that time period in a deidentified fashion. Medication usage will be reviewed as well as the standard of care information from the duramorph monitoring will be retrieved.

Enrollment

3 patients

Sex

Female

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • OSA screen negative per hospital protocol
  • age 18 or greater
  • BMI>35
  • consent to participate to wear capnography and pulse oximetry monitoring devices post delivery

Exclusion criteria

  • Spanish speaking only
  • under age 18
  • contraindication to receiving drugs utilized in delivery anesthetic

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

3 participants in 1 patient group

capnography monitoring
Other group
Description:
single arm, all subjects receiving duramorph will receive capnography monitoring
Treatment:
Device: Capnography monitoring

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems